Purpose: To study the prevalence of TEM-, SHV- and GES-type β -lactamases among
Escherichia coli
and
Klebsiella pneumoniae
strains having ceftazidime MICs higher than 2 mg/L.
Methods: A total of 63
E. coli and 41
K. pneumoniae isolated from five different university hospitals were studied for the existence of TEM-, SHV- and GES-type β -lactamases. Susceptibility tests were carried out according to the criteria of National Committee for Clinical Laboratory Standards. MICs were obtained by agar dilution method. Existence of extended-spectrum β -lactamases (ESBLs) were assessed by double-disc synergy test (DDST). Existence of the above-mentioned β -lactamase genes were studied both by PCR with specific oligonucleotide primers and isoelectric focusing methods.
Results: None of the isolates were carbapenem-resistant. DDSTs were positive in 50 (79.3%) and 33 (80.5%) of
E. coli and
K. pneumoniae , respectively. TEM gene was detected in 41 (65.1%) and 19 (46.3%), whereas SHV gene in 18 (28.6%) and 20 (48.8%) of
E. coli and
K. pneumoniae strains, respectively. GES genes were not detected.
Conclusions: TEM and SHV genes are highly prevalent among ESBL-producing
E. coli and
K. pneumoniae , whereas GES-type ESBLs are absent and found not to be responsible of ceftazidime resistance in Turkish hospitals.
